コンテンツへスキップ
Merck
  • Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones.

Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones.

Bioorganic & medicinal chemistry (2007-12-26)
Abdel-Rahman B A El-Gazzar, Mervat M El-Enany, Mahmoud N Mahmoud
要旨

Novel series of pyrimido[4,5-b]quinolines (3a-c), triazolo[4',3':1,2]pyrimido[4,5-b]-quinolines (7a-e, 9, and 14), tetrazolo[4',3':1,2]pyrimido[4,5-b]quinolin-5-one (13), [1,3]-pyrazolo[3',2':1,2]pyrimido[4,5-b]quinolines (12a and 12b), and 2-pyrazolyl-pyrimido[4,5-b]-quinolines (15, 16a, 16b, and 19) have been synthesized. Some of the new compounds were tested against various bacteria and fungi species. In addition, the analgesic and anti-inflammatory activities are reported. Compounds 8 and 9a possess high activity toward the fungi as compared with the reference drug Nystatin. The tested compounds 5 and 8 have moderate anti-inflammatory activities. Moreover compounds 5, 8, 10, and 16a, have activities higher than the reference drug in peripheral analgesic activity testing, Compounds 5, 7a, 11a, and 16a have potencies as the reference drug in central analgesic activity testing.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アセチルサリチル酸, ≥99.0%
Sigma-Aldrich
インドメタシン, 98.5-100.5%, meets EP testing specifications
Sigma-Aldrich
Aspirin, meets USP testing specifications
Sigma-Aldrich
ナリジクス酸, ≥98%
Sigma-Aldrich
アセチルサリチル酸, analytical standard
Sigma-Aldrich
インドメタシン, meets USP testing specifications